An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 7 , ISSUE 2 ( May-August, 2015 ) > List of Articles

RESEARCH ARTICLE

Evaluation of Omeprazole in the Treatment of Laryngopharyngeal Reflux Disease: A Single Center, Prospective and Randomized Study

Kartik Doshi, Ashish Varghese, Dinesh K Badyal

Keywords : Laryngitis,Laryngopharyngeal reflux,Omeprazole,Proton-pump inhibitors

Citation Information : Doshi K, Varghese A, Badyal DK. Evaluation of Omeprazole in the Treatment of Laryngopharyngeal Reflux Disease: A Single Center, Prospective and Randomized Study. Int J Otorhinolaryngol Clin 2015; 7 (2):45-50.

DOI: 10.5005/jp-journals-10003-1186

Published Online: 00-08-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aims

To assess efficacy and safety of omeprazole in laryngitis due to laryngopharyngeal reflux disease (LPRD).

Materials and methods

It was a prospective, randomized, open label study conducted in 90 patients with laryngitis due to LPRD. Group A (n = 45) received omeprazole and advice about life style modification, group B (n = 45) received only advice about life style modification. Reflux symptom index (RSI), reflux finding score (RFS), quality of life (QoL) and voice handicap index (VHI) were evaluated at 0, 4 and 8 weeks.

Results

P ercentage r eduction i n R SI a nd R FS w as s ignificantly higher in group A after 8 weeks (37 vs 29%, 18 vs 13% respectively). Excess throat mucus, clearing of throat and erythema of posterior larynx improved considerably in group A compared to group B.

Conclusion

Omeprazole could be a significant addition to life style modification in LPRD patients particularly for signs and symptoms, such as excess throat mucus, clearing of throat and erythema of posterior larynx.

How to cite this article

Doshi K, Varghese A, Badyal DK. Evaluation of Omeprazole in the Treatment of Laryngopharyngeal Reflux Disease: A Single Center, Prospective and Randomized Study. Int J Otorhinolaryngol Clin 2015;7(2):45-50.


PDF Share
  1. Evaluation and management of laryngopharyngeal reflux. J Am Med Assoc 2005;294(12):1534–1540.
  2. A systematic review of the role of proton pump inhibitors for symptoms of laryngopharyngeal reflux. Clin Otolaryngol 2006;31(1):20–24.
  3. Validity and reliability of the reflux symptom index. J Voice 2002;16(2):274–277.
  4. The validity and reliability of the reflux finding score. Laryngoscope 2001;111(8):1313–1317.
  5. Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis 2013;4(6):287–301.
  6. Metaanalysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment Pharmacol Ther 2003;17(10):1237–1245.
  7. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized and double-blind study. Laryngoscope 2001;111(12):2147–2151.
  8. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006;116(2):254–260.
  9. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol 2010;8(9):770–776.
  10. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001;96(4):979–983.
  11. Proton pump inhibitors versus placebo in the treatment of LPR: a meta-analysis of nine RCTs. Otolaryngol Head Neck Surg 2013;149:P88–P88.
  12. Laryngeal epithelial defenses against laryngopharyngeal reflux: investigations of E-cadherin, carbonic anhydrase isoenzyme III and pepsin. Ann Otol Rhinol Laryngol 2005;114(12):913–921.
  13. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope 2010;120(4):777–782.
  14. New Delhi, India 2006. Available at: http://icmr.nic.in/ethical_guidelines.pdf. Accessed on 09/04/2015.
  15. J Am Med Assoc 2013;310(20):2191–2194.
  16. Development and validation of the voice handicap index-10. Laryngoscope 2004;114(9):1549–1556.
  17. Short, self-report voice symptom scales: psychometric characteristics of the voice handicap index-10 and the vocal performance questionnaire. Otolaryngol Head Neck Surg 131(3):232–235.
  18. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101 101(4 Pt 2 Suppl 53):1–78.
  19. GERD-induced ENT symptoms: a prospective placebo controlled study with omeprazole 40 mg a day. Gastroenterol 120(5):A16.
  20. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled doubleblind crossover study. Scand J Gastroenterol 2003;38(5):462–467.
  21. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology—head and neck surgery. Otolaryngol Head Neck Surg 2002;127(1):32–35.
  22. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004;131(4):342–350.
  23. Laryngopharyngeal reflux: consensus conference report. J Voice 1996;10(3):215–216.
  24. Safety profile of the proton-pump inhibitors. Am J Health Syst Pharm 1996;56(23 suppl 4):S11–17.
  25. Proton pump inhibitors and their drug interactions: an evidence-based approach. Eur J Gastroenterol Hepatol 2001;13(5):611–616.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.